Insiders · Profile

Doyle Janeen Noel

Chief Corp. & Bus. Dev. Ofcr at Janux Therapeutics. Filing since 2 Jun 2026. CIK 0002069239

Company

Date

Role

Action

Amount

Of holding

2 Jun 2026

Chief Corp. & Bus. Dev. Ofcr

Sold at will

4,059

$56.94K

5.1%

1 decision on file.